Hepatitis B oral vaccine (PlantPharm BioMed)

PlantPharm BioMed's Hepatitis B oral vaccine is a plant-based, oral solid dose vaccine candidate designed to prevent Hepatitis B virus (HBV) infection. The vaccine utilizes genetically modified plants as biofactories to produce the Hepatitis B surface antigen (HBsAg). Delivered orally as a tablet or capsule, the vaccine is designed to induce both mucosal and systemic immune responses. This platform technology aims to provide a shelf-stable, cost-effective alternative to traditional injectable vaccines, facilitating distribution in resource-limited settings. The candidate has completed an FDA-authorized Phase 1 double-blind human clinical trial, demonstrating equivalence to standard injectable vaccines.

Other names

plant-based oral Hepatitis B vaccineoral solid dose Hepatitis B vaccine